Edward Morrow Atkinson Iii is EVP, Chief Technical Ops. Off. of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 15,972 shares of VRTX, which is worth approximately $6.52 Million. The most recent transaction as insider was on Jun 12, 2024, when has been sold 7,288 shares (Common Stock) at a price of $478.0 per share, resulting in proceeds of $3,483,664. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16K
0% 3M change
n/a 12M change
Total Value Held $6.52 Million

Edward Morrow Atkinson III Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2024
SELL
Open market or private sale
$3,483,664 $478.0 p/Share
7,288 Reduced 31.33%
15,972 Common Stock
Jun 11 2024
SELL
Payment of exercise price or tax liability
$3,288,895 $481.96 p/Share
6,824 Reduced 22.68%
23,260 Common Stock
May 14 2024
BUY
Grant, award, or other acquisition
-
14,112 Added 31.93%
30,084 Common Stock
Feb 26 2024
SELL
Open market or private sale
$375,893 $425.7 p/Share
883 Reduced 5.24%
15,972 Common Stock
Feb 23 2024
SELL
Payment of exercise price or tax liability
$714,180 $431.79 p/Share
1,654 Reduced 8.94%
16,855 Common Stock
Feb 21 2024
SELL
Open market or private sale
$506,545 $421.77 p/Share
1,201 Reduced 6.09%
18,509 Common Stock
Feb 20 2024
SELL
Open market or private sale
$337,052 $420.79 p/Share
801 Reduced 3.91%
19,710 Common Stock
Feb 20 2024
SELL
Payment of exercise price or tax liability
$473,152 $420.58 p/Share
1,125 Reduced 5.2%
20,511 Common Stock
Feb 16 2024
SELL
Payment of exercise price or tax liability
$636,439 $424.01 p/Share
1,501 Reduced 6.49%
21,636 Common Stock
Feb 12 2024
SELL
Open market or private sale
$383,679 $420.24 p/Share
913 Reduced 3.8%
23,137 Common Stock
Feb 09 2024
SELL
Payment of exercise price or tax liability
$351,719 $422.74 p/Share
832 Reduced 3.34%
24,050 Common Stock
Feb 07 2024
BUY
Grant, award, or other acquisition
-
4,743 Added 16.01%
24,882 Common Stock
Feb 06 2024
BUY
Grant, award, or other acquisition
-
6,260 Added 23.71%
20,139 Common Stock

Also insider at

ETNB
89bio, Inc. Healthcare
EMA

Edward Morrow Atkinson Iii

EVP, Chief Technical Ops. Off.
San Francisco, CA

Track Institutional and Insider Activities on VRTX

Follow VERTEX PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX